Health-system pharmacy's imperative for practice model change

American Journal of Health-System Pharmacy

Volumn 69, Issue 11, 2012, Pages 972-978

  Manasse, Henri R ^a,b  

^a AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACY; ECONOMIC EVALUATION; EMERGENCY WARD; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HUMAN; MEDICAL ETHICS; MEDICAL PERSONNEL; MEDICAL PRACTICE; MEDICAL RESEARCH; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; PRACTICE MODEL CHANGE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; THEORETICAL MODEL; TREATMENT OUTCOME; UNITED STATES;

EID: 84861474839     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110740     Document Type: Review

References (39)

1. Directions for clinical practice in pharmacy. Proceedings of an invitational conference conducted by the ASHP Research and Education Foundation and the American Society of Hospital Pharmacists. Am J Hosp Pharm. 1985; 42:1287-342.
2. Pharmacy in the 21st Century conference. Am J Pharm Educ. 1989; 53 (suppl):1s-78s.
3. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-43. (Pubitemid 20138134)
4. Implementing pharmaceutical care. Proceedings of an invitational conference conducted by the American Society of Hospital Pharmacists and the ASHP Research and Education Foundation. Am J Hosp Pharm. 1993; 50:1585-656.
5. Goldstein GM. Lessons in disaster: McGeorge Bundy and the path to war in Vietnam. New York: Times/Holt; 2008:144.
6. Haddad AM, Buerki RA, eds. Ethical dimensions of pharmaceutical care. New York: Haworth/Pharmaceutical Products; 1996.
7. Badaracco JL. Defining moments: when managers must choose between right and right. Boston: Harvard Business School; 1997.
8. Manasse HR Jr. Conference concluding remarks. Am J Health-Syst Pharm. 2009; 66(suppl 3):S77-8.
9. Brushwood DB. The duty to counsel: reviewing a decade of litigation. DICP. 1991; 25:195-204.
10. Elwyn G, Edwards A, Britten N. "Doing prescribing": how might clinicians work differently for better, safer care. Qual Saf Health Care. 2003; 12(suppl 1):133-6.
11. Chisholm-Burns MA, Lee JK, Spivey CA et al. US pharmacists' effect as team members on patient care: systematic review and meta-analysis. Med Care. 2010; 48:923-33.
12. Chisholm-Burns MA, Graff Zivin JS, Lee JK et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Health-Syst Pharm. 2010; 67:1624-34.
13. Cobaugh DJ, Amin A, Bookwalter T et al. ASHP-SHM Joint Statement on Hospitalist-Pharmacist Collaboration. Am J Health-Syst Pharm. 2008; 65:260-3.
14. National Quality Forum. Safe Practices for Better Healthcare-2009 update.www. q u a l i t y forum.or g / Publications/2009/03/Safe-Practices- for-BetterHealthcare%e2%80%932009-Update.aspx (accessed 2010 Oct 28).
15. Society of Critical Care Medicine, American College of Clinical Pharmacy. Position paper on critical care pharmacy services. Pharmacotherapy. 2000; 20:1400-6.
16. American Academy of Family Physicians. Pharmacists(positionpaper). www.aafp.org/online/en/home/policy/policies/p/pharmacistspositionpaper.html (accessed 2012 Jan 5).
17. Committee on the Future of Emergency Care in the United States Health System. Hospital-based emergency care: at the breaking point. Washington, DC: National Academies Press; 2007.
18. Manasse HR Jr, Speedie MK. Pharmacists, pharmaceuticals, and policy issues shaping the work force in pharmacy. Am J Health-Syst Pharm. 2007; 64:e30-48.
19. National Association of Boards of Pharmacy. Survey of pharmacy law-2011. Mount Prospect, IL: 2010:99.
20. American Society of Health-System Pharmacists. ASHP criticizes AMA commentary on pharmacist scope of practice. www.ashp.org/menu/News/News Capsules/Article.aspx?id=345 (accessed 2012 Jan 5).
21. Wellikson L. Health care imperative for practice model change. Am J Health-Syst Pharm. 2011; 68:1096-7.
22. Taylor ML. Changing the pharmacy practice model: a health-system executive's view. Am J Health-Syst Pharm. 2011; 68:1097-8.
23. Wechsler J. Healthcare reform requires a hard look at drug costs and savings. http://formularyjournal.modernmedicine.com/ formulary/ Modern+Medicine+Now/Healthcare-reform-requires-a-hard-look-at-drug-cos/ ArticleStandard/ Article/detail/579386 (accessed 2012 Jan 5).
24. Health as a Human Capital Foundation. Homepage. www.hhcfoundation.org/ hhcf/About.aspx (accessed 2010 Oct 28).
25. U.S. House of Representatives. Committee on Government Oversight and Reform. Financial impacts of waste, fraud, and abuse in pharmaceutical pricing. http://oversight.house.gov/index. php?option=com-content&view=article &id=2628:financial-impacts-of-waste-fraud-and-abuse-in-pharmaceutical- pricing& catid=42:hearings&Itemid=2 (accessed 2010 Oct 28).
26. American Society of Health-System Pharmacists. 2009 ASHP pharmacy staffing survey results. www.ashp.org/Doc Library/MemberCenter/SPPM/ASHP- Staffing-Survey-2009.aspx (accessed 2010 Oct 28).
27. Open Congress for the 112th United States Congress. H.R. 3590: Patient Protection and Affordable Care Act. www.opencongress.org/bill/111-h3590/show (accessed 2010 Oct 28).
28. HealthCare.gov. Take health care into your own hands. www.healthcare.gov (accessed 2012 Jan 5).
29. Health Resources and Services Administration. HHS budget makes smart investments, protects the health and safety of America's families. www.hrsa.gov/about/news/pressreleases/2010/100201a.html (accessed 2012 Jan 24).
30. Food and Drug Administration. Identification of drug and biological products deemed to have risk evaluation and mitigation strategies for purposes of the Food and Drug Administration amendments act of 2007. Fed Regist. 2008; 73:16313-4.
31. Lavine G. CMS expands list of hospital medical mistakes it will not cover. Am J Health-Syst Pharm. 2008; 65:1686-8. News.
32. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.
33. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. JAMA. 1995; 274:35-43.
34. Bates DW, Boyle DL, Vander Vliet MB et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995; 10:199-205.
35. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001; 31:199-205. (Pubitemid 32592646)
36. Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients-a prospective cross-sectional study. S Afr Med J. 2006; 96:1255-9. (Pubitemid 46070629)
37. Vincer MJ, Murray JM, Yuill A et al. Drug errors and incidents in a neonatal intensive care unit: a quality assurance activity. Am J Dis Child. 1989; 143:737-40. (Pubitemid 19145413)
38. Kaushal R, Bates DW, Landrigan C et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001; 285:2114-20. (Pubitemid 32367829)
39. Calaprice A, ed. The new quotable Einstein. Princeton, NJ: Princeton Univ. Press; 2005:287.